A drug with the SMILES Cc1sc2ncn(CC(=O)NCCCC(=O)N3CCN(Cc4ccc5c(c4)OCO5)CC3)c(=O)c2c1C has a human ether-à-go-go related gene (hERG) inhibition at a concentration of 1uM of 9.657\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
Cc1sc2ncn(CC(=O)NCCCC(=O)N3CCN(Cc4ccc5c(c4)OCO5)CC3)c(=O)c2c1C
Cc1sc2ncn(CC(=O)NCCCC(=O)N3CCN(Cc4ccc5c(c4)OCO5)CC3)c(=O)c2c1C
N-[4-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-4-oxobutyl]-2-(5,6-dimethyl-4-oxothieno[2,3-d]pyrimidin-3-yl)acetamide